Home / Biotechnology / cDNA And o

cDNA And oDNA Microchips Market By Application (Gene Identification & Detection, Comparative Genomic Hybridization, Gene Expression Profiling, Drug Discovery, Others), By End User (Research Organizations And Institutes, Biotech Companies, Clinical Laboratories) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

New technology evaluation in the cDNA and cDNA microchips market shows significant growth during the forecast period

The global cDNA and oDNA microchip market are expanding rapidly; it was worth $458.2 million in 2017 and is expected to be worth $1,050.3 million by 2026. The global market is growing productively at a CAGR of 9.7% during the forecast period. The incorporation of new technologies in the biological and electronic components of microchips is enhancing their overall growth globally. Advancements in nanotechnology, clinical diagnostics, cancer research, and agriculture also reflect favorable growth during the forecast period. The high global prevalence of cancer provides a major opportunity in the global market. The increasing popularity of cDNA and oDNA microchips has encouraged many international players to enter the marketplace and profit from its growing demand on a global scale, especially in countries such as the U.S., Germany, Israel, China, India, Singapore, Japan, and South Korea. The DNA microarray market in these countries is poised for enormous growth as drug discovery, biotech, cancer research, and clinical trials intensify the overall growth on a global scale.

The rising adoption of biochips for personalized medicine, growing applications in cancer, and technological assessments in advanced DNA microarray systems and sensors are the major drivers of the cDNA and oDNA microchip markets. Additionally, the advanced technology in gene chips has now become very popular in the medical research sector and drug discovery, as it considerably brings down the overall research time with enhanced and quick results. This particular technology is mainly used to simultaneously quantify the expression levels of thousands of genes. However, outsourcing of bioprocessing activities by pharmaceutical and biotechnology companies, strict regulations, and high instrumentation expenses in the developing markets may hinder the market's development to a certain extent during the forecast period.

Market Synopsis

Gene expression applications are expected to register higher growth by the end of 2026.

In 2017, gene expression and profiling in the application segment held the maximum revenue share. The penetration of this segment is high due to its sophisticated stability, low limits of gene detection, and wide response range. The advanced product lines play highly complementary roles in genomics, molecular biology, and life science research.

In addition to genetic applications, DNA microarrays are also utilized in toxicological, protein, and biochemical research in developed countries. The manufacturers are expanding the usage with higher technology assessments utilized for top applications such as cancer diagnosis, microbial genotyping, genomics, agricultural biotechnology, drug discovery, single nucleotide polymorphism (SNP) analysis, and other applications, including environmental biology, screening, and monitoring of patient data in clinical trials, proteomics, and toxicogenomics. For example, Toyo Seikan Group Holdings (Japan) develops chips designed for definite applications. They have recently developed a DNA chip for examining fungi. The DNA chip divides more than 630 species of fungi into 32 groups and can test them instantaneously.

Research organizations and institutes to dominate the market with a significant CAGR.

The growth and development of the cDNA and oDNA microchips in research organizations and biotech firms will gain traction during the forecast period. Microchips containing cDNA and oDNA are now recognized as important tools for biomarker discovery, cancer research, molecular cytogenetics, agricultural biotechnology, and genomics. The increased use of genome testing is generating a sizable revenue share globally. A significant increase in drug discovery applications, as well as gene identification and detection, indicates promising opportunities in the near future.

Furthermore, administrations of cDNA and oDNA microchips as biochips, lab on a chip, clinical proteomics, and advanced cancer diagnostics show significant market growth. The global market is largely driven by developments in personalized medicine, the need for early cancer detection, and government or private funding in developing nations for advanced research.

North America has a dominant position due to increasing applications, rapid new technology launches, and the presence of top players.

Presently, the U.S. generates the largest market share in the global cDNA and oDNA microchip market, which can be attributed to the increasing adoption of DNA microarrays and progress in the fields of biotechnology, microelectronics, and nanotechnology. The North American cDNA and oDNA microchips market is driven by applications in drug discovery and development, a higher preference for compact DNA microarrays, a shift towards the use of live model systems for gene identification and evaluation, and growing demand for advanced research in cancer and the diagnostics industry.

Key factors contributing to the overall growth of the industry include rising R&D in the gene expression profiling segment, increasing adoption of personalized medicine, and the development of miniaturized analytical equipment or chips on a global scale. Furthermore, the biochips market in the Asia Pacific and Europe is expected to grow rapidly during the forecast period. The increase in biopharmaceutical companies from the Asia Pacific, especially in countries such as China, South Korea, and India, coupled with the recent trend of outsourcing research processes to Asian countries for various genome applications, would drive the market.

The presence of multinational manufacturers with a strong technology portfolio in the developed regions

Top manufacturers in the cDNA and oDNA microchips market are Sequenom, Inc., GE Healthcare, Thermo Fisher Scientific, Roche Nimblegen, Biometrix Technology, Cepheid, Agilent Technologies, Inc., Applied Microarrays, Inc., DNA Chip Research, Inc., DNA Microarray, Inc., Greiner Bio-One GmbH, Illumina, Inc., Scienion AG, Life Technologies Corporation, Toray International UK Ltd., Affymetrix, Inc., and others.

Major corporations are implementing advanced approaches along with new technology assessments in new DNA microarray models for drug discovery, medical diagnostics, and advanced biotech research. For instance, in June 2017, CellChipGroup at the Vienna University of Technology developed a miniaturized wound healing system (a chip for wound healing measurement). Additionally, in September 2017, GSI Lumonics, Inc. and NEN Life Science Products signed an agreement to jointly market laser scanner systems and DNA microarray systems globally.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

The current report also includes qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities, which provide a more comprehensive understanding of the overall cDNA and oDNA microchip market. The global report also includes a graphical representation of the competitive landscape based on market initiatives and strategies, technology portfolios, and business strengths.

Key questions are answered in this report.

  • What are the current market trends and dynamics in the cDNA and oDNA microchip markets, and what are the valuable opportunities for emerging players?
  • What are the current dynamics in the DNA microchip market and the most valuable opportunities for emerging players?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • What application type has the largest market share, and why?
  • What is the impact of the high cost of DNA microarray processes in developing markets?
  • What are the products and brands in the DNA microchip industry that are growing most significantly, and why?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and the Middle East and Africa?

Frequently Asked Questions:

The market for cDNA And oDNA Microchips is expected to reach US$ 1,050.3 Mn in 2026.

The cDNA And oDNA Microchips market is expected to see significant CAGR growth over the coming years, at 9.7%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Illumina, Inc.,Sequenom, Inc.,GE Healthcare,Thermo Fisher Scientific,Roche Nimblegen are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Nov 2018
Category:  Biotechnology
Report ID:   59437
Report Format:   PDF
Pages:   120
Rating:    4.4 (69)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support